Skip to content

Movement & Strength

The 10,000 steps myth: where the number came from and what actually counts

The 10,000-step goal began as the name of a 1965 Japanese pedometer, not as a research finding. Walking more does lower the risk of early death, heart disease and dementia, but most of the benefit arrives well before 10,000, and the curve has no cliff. Falling short is not failing, and brisk pace, stairs, short hard bursts and strength training each add benefits a step count cannot see.

By the glp1.how editorial teamReviewed 9 min read

Evidence-backed

People who walk 7,000 steps a day have a 47% lower risk of dying early than people who walk 2,000. That figure comes from a 2025 review of 57 studies, and it says nothing special happens at 10,000 (Ding et al., Lancet Public Health, 2025, DOI (external link)). The famous target is a good goal for some people. It was never a pass mark.

Where the 10,000 comes from

The number started as a product name. In 1965 the Japanese company Yamasa Clock sold a pedometer called the Manpo-kei, which translates as "10,000 steps meter." It launched in the fitness enthusiasm that followed the 1964 Tokyo Olympics, and walking clubs built around the device spread across Japan. Harvard epidemiologist I-Min Lee has called it "a made-up number in the sense that 10,000 sounds good, it's easy to remember," and no studies of 10,000 steps existed at the time (Popular Science (external link)).

The research literature tells the same story. A 2004 review traced the target to "Japanese walking clubs and a business slogan 30+ years ago" (Tudor-Locke et al., Sports Medicine, 2004, DOI (external link)). A 2019 JAMA Internal Medicine study opened by saying the number "has limited scientific basis" (Lee et al., JAMA Internal Medicine, 2019, DOI (external link)).

The evidence often cited for 10,000 steps

The number was invented, but it was not a bad guess:

  • Some large studies find benefit all the way up to about 10,000. In 78,500 UK adults wearing wrist trackers, more steps went with lower risk of death, heart disease and cancer "up to approximately 10,000 steps" (del Pozo Cruz et al., JAMA Internal Medicine, 2022, DOI (external link)). A second UK analysis of 72,174 people put the lowest risk of death at 9,000 to 10,500 steps a day (Ahmadi et al., British Journal of Sports Medicine, 2024, DOI (external link)).
  • One meta-analysis found no ceiling. Risk fell in a straight line from 2,700 to 17,000 steps a day (Jayedi et al., Sports Medicine, 2022, DOI (external link)).
  • A goal gets people moving. Across 26 studies, people given a pedometer walked about 2,500 more steps a day, and having a step goal such as 10,000 was an important predictor of that increase (Bravata et al., JAMA, 2007, DOI (external link)).
  • Researchers have called it reasonable. A 2011 review judged 10,000 steps a day "reasonable" for healthy adults, while noting that some groups walk far less (Tudor-Locke et al., International Journal of Behavioral Nutrition and Physical Activity, 2011, DOI (external link)).

The evidence against a 10,000-step threshold

  • Most of the benefit comes early. The 2025 review found the risk curve for early death, heart disease, dementia and falls bends at around 5,000 to 7,000 steps. After that, extra steps still help, but each one helps less (Ding et al., 2025, DOI (external link)).
  • The plateau depends on age. Pooling 15 cohorts, the risk of death stopped falling at 6,000 to 8,000 steps for adults aged 60 and over, and at 8,000 to 10,000 for younger adults (Paluch et al., Lancet Public Health, 2022, DOI (external link)).
  • Benefit starts very low. In 111,309 people, a measurable drop in the risk of death appeared at about 2,500 steps a day compared with 2,000. The lowest risk was at about 8,800 steps for death and about 7,100 for heart disease (Stens et al., Journal of the American College of Cardiology, 2023, DOI (external link)).
  • Every 1,000 counts. Across 17 cohorts and almost 227,000 people, each extra 1,000 steps a day went with a 15% lower risk of death (Banach et al., European Journal of Preventive Cardiology, 2023, DOI (external link)).
  • In older women, 4,400 beat 2,700. Women averaging about 4,400 steps had a 41% lower death rate than those averaging about 2,700, and the benefit leveled off at about 7,500 (Lee et al., 2019, DOI (external link)).
  • You do not need to hit it every day. Among 3,101 US adults, people who reached 8,000 steps on only one or two days a week had a 10-year risk of death 14.9 percentage points lower than people who never did. Reaching it on three to seven days gave 16.5 points (Inoue et al., JAMA Network Open, 2023, DOI (external link)).

One limit applies to both sides. Almost all of this is observational research. People who are already ill walk less, so part of the link runs backwards, even after researchers adjust for health. No trial has assigned people to 10,000 steps versus 7,000 and followed them for years. Wrist trackers, phones and research devices also count steps differently, so your 8,000 may not be a study's 8,000.

The verdict

True: walking more is linked with better health, and for adults under 60 the benefit keeps growing to somewhere around 8,000 to 10,000 steps. If you enjoy hitting 10,000, nothing here says stop.

False: that 10,000 is a threshold, that it came from research, or that a day under 10,000 is a failed day. The curve has no cliff. In most pooled studies it is steepest at the low end, so going from 3,000 to 5,000 steps likely does more for your health than going from 8,000 to 10,000. (One meta-analysis found a straight-line decline instead, so treat this as likely, not certain.) If you are well short of 10,000, you are on the part of the curve where each extra step probably counts most.

What steps actually do for your health

Compared with 2,000 steps a day, 7,000 steps a day was linked with (Ding et al., 2025, DOI (external link)):

OutcomeLower risk
Death from any cause47%
Death from heart disease47%
Dementia38%
Death from cancer37%
Falls28%
Developing heart disease25%
Depressive symptoms22%
Type 2 diabetes14%

The authors rated the certainty as moderate for most of these, low for death from heart disease, and very low for falls. Getting cancer in the first place was 6% lower, which was not statistically significant.

In a separate study of 4,840 US adults aged 40 and over, 8,000 steps a day halved the risk of death compared with 4,000 (hazard ratio 0.49), and 12,000 lowered it further (hazard ratio 0.35) (Saint-Maurice et al., JAMA, 2020, DOI (external link)).

What else counts as much, or more

A step counter sees one thing: how many times your foot lands. It cannot see effort, load or timing. Several activities bring benefits of a similar size for far less time, and one brings a benefit that steps never will.

ActivityDose studiedWhat was foundSource
Short hard bursts in daily life (fast stair climbing, hurrying uphill, carrying shopping)Three bursts a day of one to two minutes, in people who do no exercise38% to 40% lower risk of death, 48% to 49% lower risk of death from heart diseaseStamatakis et al., Nature Medicine, 2022, DOI (external link)
The same burstsAbout 4.5 minutes a day in total20% lower risk of cancerStamatakis et al., JAMA Oncology, 2023, DOI (external link)
Strength training30 to 60 minutes a week10% to 17% lower risk of death, heart disease, cancer and diabetesMomma et al., British Journal of Sports Medicine, 2022, DOI (external link)
Climbing stairsRegular stair climbing, 9 studies, 480,479 people39% lower risk of death from heart disease, 24% lower risk of death from any causePaddock et al., American Journal of Cardiovascular Drugs, 2026, DOI (external link)
Light walking breaks during long sittingShort, easy walks through the dayLower blood sugar and insulin after meals than sitting, and lower than standing breaksBuffey et al., Sports Medicine, 2022, DOI (external link)
Walking fasterAbout 100 steps a minute counts as moderate intensityAt under 5,000 steps a day, a brisker best half hour went with lower risk of deathTudor-Locke et al., 2019, DOI (external link); Wei et al., 2026, DOI (external link)

The same caution applies: the burst, stair and strength studies are observational too. A US repeat of the burst research found a similar pattern, but the result was no longer statistically clear once people with existing heart disease or cancer were left out (Koemel et al., International Journal of Behavioral Nutrition and Physical Activity, 2026, DOI (external link)).

The practical reading: a day with 5,000 steps, three flights of stairs taken fast and a 20-minute strength session may well be a better day than one with 10,000 slow steps.

Why this matters on a GLP-1

Low-energy days are part of treatment. Eating far less, nausea after a dose increase, and fatigue all cut your step count, and a rigid 10,000 target turns those days into failures. The research says a 4,000-step day still counts.

Steps also do little for muscle. Weight loss on a GLP-1 takes some muscle along with fat, and walking is good for the heart but does little to hold on to it. In a trial of 160 dieting older adults with obesity, the group doing only aerobic exercise lost 5% of its lean mass over six months, against 2% with resistance training and 3% with both combined (Villareal et al., New England Journal of Medicine, 2017, DOI (external link)). Strength training protects muscle, and a step counter gives it no credit. See why strength training matters on a GLP-1 and the beginner's resistance-training plan.

Exercise also helps the weight stay off. In a one-year trial of 195 adults who had already lost 13.1 kg, a structured exercise program plus liraglutide kept off 9.5 kg more than placebo, against 6.8 kg for liraglutide alone and 4.1 kg for exercise alone. The combination also cut body fat percentage about twice as much as either one (Lundgren et al., New England Journal of Medicine, 2021, DOI (external link)). A year after all treatment stopped, people who had exercised regained less than people who had taken liraglutide alone (Jensen et al., EClinicalMedicine, 2024, DOI (external link)). That program was moderate to vigorous exercise, not a step target.

If your real goal is changing body composition and not only the scale, weight loss vs. body recomposition explains why the type of activity matters more than the count.

How to respond to the myth

  • Start from your own baseline. Check your average for a normal week and add 1,000 to 2,500 steps. That is about what pedometer programs achieve, and each extra 1,000 is linked with a 15% lower risk of death.
  • Use the one-liner. "The 10,000 came from a 1965 pedometer advert. The research says most of the benefit is in by about 7,000, and it starts at about 2,500."
  • Count the week, not the day. Reaching 8,000 on a couple of days a week was still linked with a clearly lower risk of death.
  • Add what the counter cannot see. Two strength sessions a week, stairs when they are there, and a few minutes a day of getting properly out of breath.
  • Walk after meals and break up long sitting. Short, easy walks lower the blood sugar rise after eating.
  • Keep the goal if it works for you. A target that gets you out of the door is useful. One that makes you feel like a failure at 6,000 steps is not.

The bottom line

Ten thousand steps is a marketing number that happened to land near the top of the real benefit curve for younger adults. The health gains from walking start at about 2,500 steps, are largest between 2,000 and 7,000, and level off at 6,000 to 8,000 for people over 60. Five thousand steps is not failing. On a GLP-1, the bigger gap is usually strength training, which protects muscle and which no step counter measures.

This is general education, not medical advice. If you have heart disease, joint problems, diabetes treated with insulin or a sulfonylurea, or you have been inactive for a long time, talk to your clinician before starting vigorous activity. Research findings above are attributed to PubMed-indexed articles with DOI links. The history of the Manpo-kei pedometer is from news reporting, not PubMed.

mythevidencewalkingstepsexercisemovement-strength

Common questions

Questions people often ask about this topic.

  • Where did the 10,000 steps a day goal come from?

    It came from marketing, not research. In 1965 the Japanese company Yamasa Clock sold a pedometer called the Manpo-kei, which means 10,000 steps meter, and walking clubs grew up around it. A 2004 research review traced the number to Japanese walking clubs and a business slogan. Studies testing step counts against health outcomes came decades later.

  • Is 5,000 steps a day enough?

    It is a meaningful amount. A 2025 review of 57 studies found the risk curve for early death, heart disease and dementia bends at around 5,000 to 7,000 steps a day, so much of the benefit is already in place by then. More steps still help, but each extra thousand adds less. If you are at 5,000 now, moving toward 7,000 is a reasonable next goal.

  • How many steps a day do you actually need?

    There is no single number. Benefit is measurable from about 2,500 steps a day and grows from there. A pooled analysis of 15 cohorts found the risk of death stopped falling at 6,000 to 8,000 steps for adults aged 60 and over, and at 8,000 to 10,000 for younger adults. The most useful target is usually 1,000 to 2,000 more than you average now.

  • Am I failing if I don't reach 10,000 steps?

    No. The relationship between steps and health is a curve with no cliff at 10,000. In most pooled studies the curve is steepest at the low end, so going from 3,000 to 5,000 steps a day likely does more than going from 8,000 to 10,000. In one US study, people who reached 8,000 steps on only one or two days a week still had a clearly lower risk of death over 10 years than people who never did.

  • Does walking pace matter, or just the number of steps?

    Both matter, and pace matters most when your step count is low. About 100 steps a minute counts as moderate intensity. In a 2026 UK study, people under 5,000 steps a day had a lower risk of death when their briskest half hour of the day was faster. If you cannot add steps, walking some of them faster is a reasonable alternative.

  • Do steps build or protect muscle on a GLP-1?

    Not much. Walking is good for the heart, blood sugar and mood, but it does little to hold on to muscle during weight loss. Strength training does: in one trial of dieting older adults, the aerobic-only group lost more lean mass than the resistance-training group. A step counter gives strength work no credit, yet cohort studies link 30 to 60 minutes a week of muscle-strengthening activity with 10% to 17% lower risk of death, heart disease, cancer and diabetes.

  • What can I do instead of 10,000 steps?

    Several things bring similar benefits in less time. In people who do no formal exercise, three bursts a day of one to two minutes of hard effort, such as climbing stairs fast, were linked with 38% to 40% lower risk of death. Regular stair climbing, strength training twice a week, and short easy walks after meals all add benefits. These findings are observational, so they show a link and not proof.

  • Are step counts from a watch or phone accurate?

    They are good enough to track your own trend, but devices count differently. Research studies mostly used hip-worn or wrist-worn accelerometers, and a wrist device, a phone in a pocket and a research monitor can give different totals for the same day. Compare your numbers with your own past weeks, and treat study thresholds as rough guides.

Evidence: For & Against

Both sides of the topic, so you can weigh the evidence yourself.

Supporting3

Challenging11

Mixed findings3

Revision history

Updated 8 times since Sep 20, 2026 · show changes
  1. v9

    Evidence sources 16 → 17

  2. v8

    Common questions revised

  3. v7

    Body revised

  4. v6

    Body revised

  5. v5

    Published

  6. v4

    Body revised

  7. v3

    Common questions 0 → 8

  8. v2

    Evidence sources 0 → 16

  9. v1

    First version

Related guides

  • Joint pain on a GLP-1: why it usually gets better, why it sometimes gets worse first · Losing weight takes real load off your knees, and the trial evidence on that is strong. But plenty of people find their joints ache more in the first months, usually because they've started moving again on deconditioned tissue, or because rapid weight loss took muscle that was helping hold the joint together. This guide covers what the research shows, what it doesn't, and how to train around sore joints.
  • A beginner's resistance-training plan on a GLP-1: sets, reps, and progression · A concrete beginner plan for the strength work you already know you should be doing on a GLP-1: the five core movement patterns, a simple 2–3x/week full-body template, beginner set and rep ranges, how progressive overload and reps-in-reserve work, and when to deload or bring in a trainer.
  • Physical Activity Guidelines for Americans · The official U.S. guidance on how much activity, including muscle-strengthening work, adults should aim for each week. The 2nd edition (2018) is still the current version as of September 2026.
  • Why strength training matters on a GLP-1 · Some of the weight you lose on a GLP-1 is lean tissue, much of it muscle: roughly 25-40% of the total in recent trials. Strength training, paired with enough protein, is the best-supported way to protect that muscle, and there's a good case for starting early in treatment.
  • How to find a personal trainer when you're on a GLP-1 · Once you've decided a trainer is worth it, the next job is picking a good one. This guide covers what credentials mean, why GLP-1 experience matters, where to look, what to ask on a first call, and the red flags that should send you elsewhere.
  • Should you get a personal trainer on a GLP-1? · You don't need a personal trainer on a GLP-1, but getting strength training right matters more than usual, because you're trying to lose fat without losing muscle. This guide covers who benefits most from a trainer, who can skip one, and the cheaper options in between.

Related terms

  • Hazard ratio · A statistic from clinical trials that compares how often an event happens over time in one group versus another; below 1 means a lower rate in the treated group.
  • Resistance training (progressive overload) · Exercise that loads your muscles against resistance and is made gradually harder over time (progressive overload) to keep or build muscle and strength.
  • Lean mass · Body weight from everything other than fat: mostly muscle, plus organs and water, and in the broad sense bone. On a DXA report, lean mass usually leaves bone out.
  • GLP-1 · A gut hormone (glucagon-like peptide-1) that stimulates insulin release, slows digestion, and reduces appetite; the target of drugs like semaglutide and liraglutide.
  • Liraglutide · A first-generation GLP-1 receptor agonist taken as a daily injection, sold as Victoza for type 2 diabetes and Saxenda for weight management, and now also as a US generic.
  • Sulfonylurea · A class of oral type 2 diabetes medications (e.g. glipizide, glimepiride, glyburide) that stimulate the pancreas to release insulin regardless of blood sugar level.

Was this helpful?

Improve this page